Access cutting-edge major bleeding treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Access major bleeding specialists in Minneapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related major bleeding treatment provided free
This is a multicentre, prospective, randomised, double-blinded, group-sequential, parallel-group, adaptive design, phase 3 study to demonstrate the haemostatic efficacy and safety of four-factor prothrombin complex concentrate, OCTAPLEX, in patients with acute major bleeding on DOAC therapy with factor Xa inhibitor. Patients will be randomised 1:1 to either of two study groups: low-dose vs. high-dose OCTAPLEX.
Sponsor: Octapharma
Check if you qualify for this major bleeding clinical trial in Minneapolis, MN
If you're searching for major bleeding treatment options in Minneapolis, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced major bleeding specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.